Alison P. Klein

36.4k total citations · 7 hit papers
146 papers, 12.5k citations indexed

About

Alison P. Klein is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Alison P. Klein has authored 146 papers receiving a total of 12.5k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Oncology, 58 papers in Cancer Research and 40 papers in Molecular Biology. Recurrent topics in Alison P. Klein's work include Pancreatic and Hepatic Oncology Research (90 papers), Cancer Genomics and Diagnostics (56 papers) and Genetic factors in colorectal cancer (25 papers). Alison P. Klein is often cited by papers focused on Pancreatic and Hepatic Oncology Research (90 papers), Cancer Genomics and Diagnostics (56 papers) and Genetic factors in colorectal cancer (25 papers). Alison P. Klein collaborates with scholars based in United States, Canada and China. Alison P. Klein's co-authors include Ralph H. Hruban, Michael Goggins, Elliot K. Fishman, Kieran Brune, Robert A. Anders, Marcia Irene Canto, Daniel A. Laheru, Anirban Maitra, Christopher L. Wolfgang and Charles J. Yeo and has published in prestigious journals such as Science, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Alison P. Klein

143 papers receiving 12.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape

2012 1.7k citations Robert A. Anders, Rajni Sharma et al. Science Translational Medicine profile →
DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer

2009 799 citations Christine A. Iacobuzio–Donahue, Shinichi Yachida et al. profile →
Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors

2021 699 citations Alison P. Klein profile →
Recent progress in pancreatic cancer

2013 690 citations Christopher L. Wolfgang, Joseph M. Herman et al. profile →
Prevalence of Unsuspected Pancreatic Cysts on MDCT

2008 625 citations Alison P. Klein, Satomi Kawamoto et al. profile →
Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene

2009 565 citations Siân Jones, Ralph H. Hruban et al. profile →
Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development

2011 562 citations Jian Wu, Hanno Matthaei et al. Science Translational Medicine profile →

Peers

Alison P. Klein

ONCOL

SURGE

EPIDE

Andrew V. Biankin Australia

Andrew M. Lowy United States

Robert L. Camp United States

Rosa F. Hwang United States

Inti Zlobec Switzerland

Russell R. Broaddus United States

James A. Fagin United States

Celina G. Kleer United States

Aurélien de Reyniès France

Sarina A. Piha‐Paul United States

Andrew V. Biankin Australia

Alison P. Klein

7.7k ×0.8

ONCOL

3.5k ×0.9

5.3k ×1.5

3.8k ×1.3

SURGE

1.6k ×0.9

EPIDE

Citations per year, relative to Alison P. Klein Alison P. Klein (= 1×) peers Andrew V. Biankin

Countries citing papers authored by Alison P. Klein

Since Specialization

Citations

This map shows the geographic impact of Alison P. Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison P. Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison P. Klein more than expected).

Fields of papers citing papers by Alison P. Klein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison P. Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison P. Klein. The network helps show where Alison P. Klein may publish in the future.

Co-authorship network of co-authors of Alison P. Klein

This figure shows the co-authorship network connecting the top 25 collaborators of Alison P. Klein. A scholar is included among the top collaborators of Alison P. Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison P. Klein. Alison P. Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Elias, Roy, Thomas R. Nirschl, Michael E. Rezaee, et al.. (2025). Clear-Cell Renal Cell Carcinoma Molecular Subtypes Differ by African and European Genetic Similarity. Cancer Research Communications. 5(5). 743–755. 1 indexed citations

Ferres, Juan Lavista, Felipe Oviedo, Caleb Robinson, et al.. (2024). Performance of explainable artificial intelligence in guiding the management of patients with a pancreatic cyst. Pancreatology. 24(7). 1182–1191. 3 indexed citations

Blackford, Amanda L., Marcia Irene Canto, Mohamad Dbouk, et al.. (2024). Pancreatic Cancer Surveillance and Survival of High-Risk Individuals. JAMA Oncology. 10(8). 1087–1087. 39 indexed citations

Dbouk, Mohamad, Takeichi Yoshida, Kanako Yoshida, et al.. (2024). Germline Pathogenic Variants in Patients With Pancreatic and Periampullary Cancers. JCO Precision Oncology. 8(8). e2400101–e2400101. 2 indexed citations

Baydogan, Seyda, Parul Agarwal, R. D. Wright, et al.. (2024). Germline Testing Identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine Tumors. Cancer Prevention Research. 17(7). 335–342. 3 indexed citations

Kim, Jihye, Chen Yuan, Laufey T. Ámundadóttir, et al.. (2023). Relationship between ABO Blood Group Alleles and Pancreatic Cancer Is Modulated by Secretor ( FUT2 ) Genotype, but Not Lewis Antigen ( FUT3 ) Genotype. Cancer Epidemiology Biomarkers & Prevention. 32(9). 1242–1248. 6 indexed citations

Patasova, Karina, Annechien E. G. Haarman, Anthony M. Musolf, et al.. (2022). Association analyses of rare variants identify two genes associated with refractive error. PLoS ONE. 17(9). e0272379–e0272379. 2 indexed citations

Porter, Nancy, Daniel A. Laheru, Bryan Lau, et al.. (2022). Risk of Pancreatic Cancer in the Long-Term Prospective Follow-Up of Familial Pancreatic Cancer Kindreds. JNCI Journal of the National Cancer Institute. 114(12). 1681–1688. 19 indexed citations

Corlin, Laura, Mengyuan Ruan, Konstantinos K. Tsilidis, et al.. (2021). Two-Sample Mendelian Randomization Analysis of Associations Between Periodontal Disease and Risk of Cancer. JNCI Cancer Spectrum. 5(3). 15 indexed citations

10.

Guan, Zoe, Rong Tang, Molly Griffin, et al.. (2021). Familial pancreatic cancer: who should be considered for genetic testing?. Irish Journal of Medical Science (1971 -). 191(2). 641–650. 1 indexed citations

11.

Thompson, Elizabeth D., Nicholas J. Roberts, Laura D. Wood, et al.. (2020). The genetics of ductal adenocarcinoma of the pancreas in the year 2020: dramatic progress, but far to go. Modern Pathology. 33(12). 2544–2563. 29 indexed citations

12.

Nanda, Neha, Christian Gauthier, Matthäus Felsenstein, et al.. (2019). Prevalence of Germline Mutations Associated With Cancer Risk in Patients With Intraductal Papillary Mucinous Neoplasms. Gastroenterology. 156(6). 1905–1913. 45 indexed citations

13.

Klein, Alison P., Sara H. Olson, Laufey T. Ámundadóttir, et al.. (2017). Impact of Sixteen Established Pancreatic Cancer Susceptibility Loci in American Jews. Cancer Epidemiology Biomarkers & Prevention. 26(10). 1540–1548. 6 indexed citations

14.

Kim, Min‐Sik, Elizabeth D. Thompson, Lanqing Huang, et al.. (2016). Using Quantitative Seroproteomics to Identify Antibody Biomarkers in Pancreatic Cancer. Cancer Immunology Research. 4(3). 225–233. 19 indexed citations

15.

Childs, Erica J., Kari G. Chaffee, Steven Gallinger, et al.. (2016). Association of Common Susceptibility Variants of Pancreatic Cancer in Higher-Risk Patients: A PACGENE Study. Cancer Epidemiology Biomarkers & Prevention. 25(7). 1185–1191. 22 indexed citations

16.

Kim, Haeryoung, Burcu Saka, Spencer Knight, et al.. (2014). Having Pancreatic Cancer with Tumoral Loss of ATM and Normal TP53 Protein Expression Is Associated with a Poorer Prognosis. Clinical Cancer Research. 20(7). 1865–1872. 70 indexed citations

17.

Hong, Seung‐Mo, Audrey Vincent, Mitsuro Kanda, et al.. (2012). Genome-Wide Somatic Copy Number Alterations in Low-Grade PanINs and IPMNs from Individuals with a Family History of Pancreatic Cancer. Clinical Cancer Research. 18(16). 4303–4312. 45 indexed citations

18.

Yachida, Shinichi, Catherine M. White, Yoshiki Naito, et al.. (2012). Clinical Significance of the Genetic Landscape of Pancreatic Cancer and Implications for Identification of Potential Long-term Survivors. Clinical Cancer Research. 18(22). 6339–6347. 199 indexed citations

19.

Wu, Jian, Hanno Matthaei, Anirban Maitra, et al.. (2011). Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development. Science Translational Medicine. 3(92). 92ra66–92ra66. 562 indexed citations breakdown →

20.

Jun, Gyungah, Hong Guo, Ronald Klein, et al.. (2009). EPHA2 Is Associated with Age-Related Cortical Cataract in Mice and Humans. PLoS Genetics. 5(7). e1000584–e1000584. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact